Abstract:Juan Zhang, Juan Wu, Hongbin Zhang, Jie Li, Hezhou Li Department of Ultrasound, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China Correspondence: Hezhou Li, The Third Affiliated Hospital of Zhengzhou University, No. 7 Kangfuqian Street, Erqi District, Zhengzhou City, Henan Province, Email Purpose: To investigate whether fetal prenatal ultrasound, fetal growth rate, and pregnancy outcome statistically differ between women infected with novel coronavirus (COVID-19) in mid-pregnancy and an uninfected control group. Patients and Methods: A retrospective analysis of biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL), and z-scores for each among 46 pregnant women diagnosed with COVID-19 in mid-pregnancy between December 01, 2022 and June 31, 2023 was conducted. A control group included 92 pregnant women negative for COVID-19 during the same period and was also analyzed. To examine fetal growth, rate of increase in BPD, HC, AC, FL, and estimated fetal weight (EFW) between second and third trimester scans were analyzed. In addition, pregnancy outcome, maternal comorbidities, and neonatal prognosis were assessed. Results: The occurrence of gestational diabetes differed significantly between groups, but the fetal growth rate and EFW did not. Similarly, pregnancy outcomes and neonatal prognoses did not differ significantly between groups. Conclusion: Gestational diabetes was a complication that differed between patients with and without COVID-19 in this study. COVID-19 in pregnant women did not affect fetal development. Therefore, these preliminary data suggest that increased fetal monitoring is not necessary for women infected with COVID-19 during the second trimester, and these women should be reassured of the low risk of adverse fetal outcomes. Keywords: novel coronavirus, pregnant women, prenatal fetal growth, pregnancy outcome, ultrasound imaging During pregnancy, hormonal and physiological changes significantly affect the respiratory system. As a result, the risk of novel coronavirus (COVID-19) infection has been higher among pregnant women than among the general population. 1 However, approximately 92–95% of pregnant women diagnosed with COVID-19 have not experienced the severe spectrum of this disease. 1–3 Binding of the angiotensin-converting enzyme receptor 2 (ACE-2) is critical for the SARS-CoV-2 virus to gain access to host cells. ACE-2 is also expressed at higher levels in the uterus and placenta of pregnant women. 4,5 Consequently, there is an increased risk of virus entry to the posterior placenta. In addition, an increased incidence of decidual arterial lesions has been observed among pregnant women positive for SARS-CoV-2. 6,7 Thus, it is possible that SARS-CoV-2 may adversely affect placental function. Perinatal mother-to-child transmission of novel coronavirus (COVID-19) and impaired placental function are additional concerns. However, prenatal ultrasound studies conducted of fetuses in pregnant women infected with SARS-CoV-2 remain very limited. 8,9 In December 2022, China eased the strict COVID-related restrictions that had previously been imposed. One of the initial observations made regarding the cases of COVID-19 reported up to that point was the high proportion of pregnant women infected during their second trimester. Duan Li et al 10 studied the effects of COVID-19 infection in late pregnancy on pregnancy outcomes in China, but few reports describe the effects of COVID-19 in mid-gestation on fetuses. Thus, our objective was to examine and compare available data from women with and without a confirmed diagnosis of COVID-19 in mid-pregnancy and to identify any statistically significant differences in regard to prenatal ultrasound fetal growth rate or neonatal prognostic outcomes. Forty-six pregnant women confirmed to be positive for COVID-19 during their second trimester were admitted to the Third Affiliated Hospital of Zhengzhou University between December 01, 2022 and June 31, 2023 and retrospectively analyzed. All enrolled women had received perinatal care at our institution and were vaccinated. All of the women had their infection confirmed by positive real-time PCR analysis of nasopharyngeal swab specimens. The patients exhibited mild symptoms (cough, fever, loss of taste and smell, sore throat, diarrhea, etc), and were diagnosed with mild COVID-19 that did not require hospitalization. 11 All patients were free of underlying diseases and complications at the time of their second ultrasound examinations. For comparison, 92 pregnant women were identified from hospital records of 4150 women who delivered during the study period. This control group -Abstract Truncated-

Evolution of Fetal Growth in Symptomatic Sars-Cov-2 Pregnancies

The association between parental SARS-CoV-2 infection in pregnancy and fetal growth restriction

SARS-CoV-2-Infektion in der Schwangerschaft und Auftreten von angeborenen Fehlbildungen – Besteht ein Zusammenhang? Auswertung von 8032 Schwangerschaften aus dem CRONOS-Register

Are Neonatal Birth Weights Reduced in Low-Risk Patients Diagnosed with COVID-19 during Pregnancy?

Correction: Multiple Gestation as a Risk Factor for SARS-CoV-2-Associated Adverse Maternal Outcome: Data From the COVID-19 Related Obstetric and Neonatal Outcome Study (CRONOS)

Adverse perinatal outcomes in gestational diabetes mellitus with and without SARS-CoV-2 infection during pregnancy: results from two nationwide registries in Germany

Maternal outcomes and risk factors for COVID-19 severity among pregnant women

Outcomes of SARS‐CoV‐2 infection in early pregnancy—A systematic review and meta‐analysis

Gestational Weight Gain and Neonatal Biometry during the COVID-19 Pandemic: A Multicenter Observational Cohort

Risk for stillbirth among pregnant individuals with SARS-CoV-2 infection varied by gestational age

Prevalence and Obstetric Management Changes During the COVID-19 Pandemic in Peripartum SARS-CoV-2-Positive Women – an Analysis of the CRONOS Registry Data

The Impact of COVID-19 during Pregnancy on Maternal Hemodynamic Function, Angiogenic Markers and Neonatal Outcome

Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review

The effect of gestational age at the time of diagnosis on adverse pregnancy outcomes in women with COVID-19

#49: Management and Outcomes of Infants Born to Mothers with SARS-CoV-2 Infection in Pregnancy

Analysis of Fetal Growth and Pregnancy Outcome in Pregnant Women Infected with Novel Coronavirus in Mid-Pregnancy

Maternal-Fetal Characteristics of Pregnant Women With Severe COVID Disease and Maternal-Neonatal Characteristics of Neonates With Early-Onset SARS-CoV-2 Infection: A Prospective Data Analysis

Exploring Pregnancy Outcomes Associated with SARS-CoV-2 Infection

SARS-CoV-2 Infection in the Second Trimester of Pregnancy: A Case Report of Fetal Intraventricular Hemorrhage After Critical COVID-19 Infection and a Brief Review of the Literature

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study

Maternal SARS-CoV-2 infection during pregnancy: possible impact on the infant